Abstract:Abstract Aging is one of the key contributing factors for chronic obstructive pulmonary diseases (COPD) and other chronic inflammatory lung diseases. Cigarette smoke is a major etiological risk factor that has been shown to alter cellular processes involving mitochondrial function, cellular senescence and telomeric length. Here we determined how aging contribute to the alteration in the gene expression of above mentioned cellular processes that play an important role in the progression of COPD and IPF. We hypothesized that aging may differentially alter the expression of mitochondrial, cellular senescence and telomere genes in smokers and patients with COPD and IPF compared to non-smokers. Total RNA from human lung tissues from non-smokers, smokers, and patients with COPD and IPF were processed and analyzed based on their ages (younger: 55 yrs). NanoString nCounter panel was used to analyze the gene expression profiles using a custom designed codeset containing 112 genes including 6 housekeeping controls (mitochondrial biogenesis and function, cellular senescence, telomere replication and maintenance). mRNA counts were normalized, log2 transformed for differential expression analysis using linear models in the limma package (R/Bioconductor). Data from non-smokers, smokers and patients with COPD and IPF were analyzed based on the age groups (pairwise comparisons between younger vs. older groups). Several genes were differentially expressed in younger and older smokers, and patients with COPD and IPF compared to non-smokers which were part of the mitochondrial biogenesis/function ( HSPD1, FEN1, COX18, COX10, UCP2 & 3 ), cellular senescence ( PCNA, PTEN, KLOTHO, CDKN1C, TNKS2, NFATC1 & 2, GADD45A ) and telomere replication/maintenance ( PARP1, SIRT6, NBN, TERT, RAD17, SLX4, HAT1 ) target genes. Interestingly, NOX4 and TNKS2 were increased in the young IPF as compared to the young COPD patients. Genes in the mitochondrial dynamics and other quality control mechanisms like FIS1 and RHOT2 were decreased in young IPF compared to their age matched COPD subjects. ERCC1 (Excision Repair Cross-Complementation Group 1) and GADD45B were higher in young COPD as compared to IPF. Aging plays an important role in various infectious diseases. Elderly patients with chronic lung disease and smokers were found to have high incidence and mortality rates in the current pandemic of SARS-CoV-2 infection. Immunoblot analysis in the lung homogenates of smokers, COPD and IPF subjects revealed increased protein abundance of important proteases and spike proteins like TMPRSS2, furin and DPP4 in association with a slight increase in SARS-CoV-2 receptor ACE2 levels. This may further strengthen the observation that smokers, COPD and IPF subjects are more prone to COVID-19 infection. Overall, these findings suggest that altered transcription of target genes that regulate mitochondrial function, cellular senescence, and telomere attrition add to the pathobiology of lung aging in COPD and IPF and other smoking-related chronic lung disease in associated with alterations in SARS-CoV-2 ACE2-TMPRSS2-Furin-DPP4 axis for COVID-19 infection.

Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States

Protecting effects of smoking against COVID-19: a community-based retrospective cohort study in middle- and older-aged adults

Attitudes Towards Smoking and COVID-19, and Changes in Smoking Behaviors Before and after the Outbreak of COVID-19: A Nationwide Cross-Sectional Survey Study in China

Association of Smoking Status with Outcomes in Hospitalised Patients with COVID-19.

Risk of death due to COVID-19 among current and former smokers in the Netherlands: a population-based quasi-cohort study

Cognition of the Relationship Between Smoking and COVID-19 and Its Impact on Daily Cigarette Consumption among Smokers

Specific persistent symptoms of COVID-19 and associations with reinfection: a community-based survey study in southern China

Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients

Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis

A Descriptive Review of Epidemiology of COVID-19 in Smokers

Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19

The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis

The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis

Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing

High Perceived Susceptibility to and Severity of COVID-19 in Smokers Are Associated with Quitting-Related Behaviors

Change in Tobacco and Electronic Cigarette Use and Motivation to Quit in Response to COVID-19

Rate and Risk Factors of Reinfection, Recurrence, and Hospital Readmission Among SARS-Cov-2 Hospitalized Patients; a National Cohort Study

Age-dependent assessment of genes involved in cellular senescence, telomere and mitochondrial pathways in human lung tissue of smokers, COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis

Smoking Cessation in Late Life is Associated with Increased Risk of All-Cause Mortality Amongst Oldest Old People: a Community-Based Prospective Cohort Study.

COVID-19 Outcome and Tobacco Product Use: Case-Control and Retrospective Cohort Studies Using Nationwide Samples

Systematic review and meta analysis of cross immunity and the smokers paradox in COVID19